David Manzano

[Legend Biotech Medical Affairs @LegendUSMA]

At #IMS2026, Dr. Adam Cohen @CohenAd_MMdoc will present long-term remission and survival outcomes from CARTITUDE-2 Cohort A evaluating BCMA-directed CAR-T therapy in multiple myeloma. Stay tuned for more.

#MultipleMyeloma #CART #mmsm

[Legend Biotech @LegendBiotech]

5-year CARTITUDE-2 Cohort A data at #IMS2026

We presented long-term findings from CARTITUDE-2 Cohort A in patients with relapsed or refractory multiple myeloma (RRMM) treated as early as second line.

Learn more: https://t.co/8XgxmqRODc

#LegendBiotech #MultipleMyeloma #CellTherapy #CART

[Legend Biotech Medical Affairs @LegendUSMA]

New data is coming to #IMS2026. Legend will share 5-year follow-up data from CARTITUDE-2 Cohort A.

Explore the details at the link below.
https://t.co/dRCCv0BHwt

[David Manzano @manzano1776]

@ClarksonsFarm1 Kier

[Legend Biotech Medical Affairs @LegendUSMA]

Legend Biotech is excited to be in Scotland this week for IMS! Join us as we share new data, connect with the scientific community, and participate in discussions shaping the future of patient care. Stay tuned for updates from the meeting.

#IMS2026 #mmsm #celltherapy

[Legend Biotech @LegendBiotech]

We’re heading to Glasgow for #IMS2026!

Sept. 23–26, Legend will share new and updated data, including long-term findings from the CARTITUDE clinical development program and real-world evidence advancing our understanding of CAR-T cell therapy in multiple myeloma.

Visit us at Booth #1453.

#LegendBiotech #MultipleMyeloma #CellTherapy #CART

[Legend Biotech @LegendBiotech]

We’re here! @SOHO 2026 is officially underway in Houston, TX, and the Legend Biotech team is on the ground. We’re looking forward to connecting with colleagues, exchanging insights, and being part of the conversations advancing the future of multiple myeloma and cell therapy.

Visit us at Booth #125 and follow along for more from #SOHO2026.

#LegendBiotech #CellTherapy

[Legend Biotech @LegendBiotech]

New data is coming at #IMS26.

At the 23rd International @Myeloma_Society Annual Meeting in Glasgow, Legend Biotech will present data from our CAR-T cell therapy, including long-term, post-authorization and real-world findings.

These insights build on learnings from our clinical program as we continue our focus on advancing scientific innovation and reaching patients globally.

Learn more about the data we’ll be sharing in Glasgow: https://t.co/l1DAqm9kNh

#LegendBiotech #CellTherapy #ClinicalResearch

[David Manzano @manzano1776]

@Stop_Cham Hey, you can’t park there

[David Manzano @manzano1776]

@batuhanppn Backward in time, and direction

[David Manzano @manzano1776]

@MapQuest What’s Map Quest?

[David Manzano @manzano1776]

@GIFs_22 White

[David Manzano @manzano1776]

@oelma__ Good one

[David Manzano @manzano1776]

@Airaasayss 16

[David Manzano @manzano1776]

@buggirl Wait until tomorrow when the neon Trump 2028 ad pops ou on the moon. 🤣
Trying the to think of a way to nicely respond to your concern but I’ll just say bless your heart, it’ll all be OK

[Legend Biotech @LegendBiotech]

What is CAR-T cell therapy?

This personalized approach uses a patient’s own T cells to help fight cancer. Learn how it works and why continued innovation matters for people living with blood cancers.

#CellTherapy #PatientsFirst #Oncology #Biotech

[Legend Biotech @LegendBiotech]

Access matters.

Our treatment center network has grown to over 150 activated treatment centers, further strengthening our nationwide footprint.

Every new treatment center represents another step toward expanding access to CAR-T cell therapy for patients in more communities. At Legend Biotech, we're committed to advancing innovation while helping connect more patients to these therapies.

#PatientsFirst #CellTherapy #CART #LegendBiotech

[David Manzano @manzano1776]

@RightScopee @ElephantSignal Nope

[Legend Biotech Medical Affairs @LegendUSMA]

The ELITE Program, sponsored by Legend Biotech, is coming soon, with applications opening this summer for US healthcare professionals.

Visit the website to learn more: https://t.co/bqXqWUJ3FA

#ELITEProgram #CellTherapy #ScientificLeadership

[David Manzano @manzano1776]

@WHLeavitt Can’t wait